Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to compare the blood
glucose-lowering effect of NN5401 (insulin degludec/insulin aspart, IDegAsp) with NN1250
(insulin degludec, IDeg) and insulin aspart (IAsp) in subjects with type 1 diabetes mellitus.